sec filings
Insider trades
Open-market buys and sales that company insiders report to the SEC on .
Side
Planned sales
Role
TVTX
Updated 10/6/2026, 8:56 AM ET.
| Stock | Side | Value | Insider | Shares | Avg price | Filed | Tags | Filing |
|---|---|---|---|---|---|---|---|---|
| TVTX Travere Therapeutics, Inc. | Sale | $13,135,397 | ROTE WILLIAM E. Chief Research Officer | 209,048 sh | at $62.83 | Filed Sep 17, 9:35 PM ET | Filing | |
| TVTX Travere Therapeutics, Inc. | Sale | $17,857,830 | Heerma Peter EVP, CHIEF COMMERCIAL OFFICER | 283,189 sh | at $63.06 | Filed Sep 17, 9:35 PM ET | Filing | |
| TVTX Travere Therapeutics, Inc. | Sale | $2,785,021 | Inrig Jula EVP, Head of R&D & CMO | 44,674 sh | at $62.34 | Filed Sep 17, 9:33 PM ET | Filing | |
| TVTX Travere Therapeutics, Inc. | Sale | $2,337,695 | REED ELIZABETH E Chief Legal Officer and GC | 37,500 sh | at $62.34 | Filed Sep 17, 9:32 PM ET | Filing | |
| TVTX Travere Therapeutics, Inc. | Sale | $25,390,729 | Dube Eric M CHIEF EXECUTIVE OFFICER, Director | 400,000 sh | at $63.48 | Filed Sep 17, 9:31 PM ET | Filing | |
| TVTX Travere Therapeutics, Inc. | Sale | $3,148,544 | Cline Christopher R. CHIEF FINANCIAL OFFICER | 50,508 sh | at $62.34 | Filed Sep 17, 9:30 PM ET | Filing | |
| TVTX Travere Therapeutics, Inc. | Sale | $335,005 | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 5,375 sh | at $62.33 | Filed Sep 17, 9:29 PM ET | Filing | |
| TVTX Travere Therapeutics, Inc. | Sale | $1,346,106 | Meckler Jeffrey A Director | 20,000 sh | at $67.31 | Filed Sep 11, 4:05 PM ET | Filing | |
| TVTX Travere Therapeutics, Inc. | Sale | $42,610 | Cline Christopher R. CHIEF FINANCIAL OFFICER | 642 sh | at $66.37 | Filed Sep 3, 4:05 PM ET | Filing | |
| TVTX Travere Therapeutics, Inc. | Sale | $632,846 | LYONS GARY A Director | 10,000 sh | at $63.28 | Filed Aug 19, 4:05 PM ET | Filing |